Product Name | Nintedanib Ethanesulfonate Salt (Synonyms: Intedanib; BIBF 1120) |
---|---|
CAS | 656247-18-6 |
Formula | C31H33N5O4.C2H6O3S |
MW | 649.76 | 539.64(free) |
MDL | MFCD26142360 |
Appearance | Yellow powder |
Storage condition | 4°C, sealed storage, away from moisture |
Nintedanib Ethanesulfonate Salt (BIBF 1120) is an inhibitor of the receptor tyrosine kinases VEGFR, FGFR, and PDGFR (IC50s = 13-34, 37-610, 59, and 65 nM for VEGFR1-3, FGFR1-4, PDGFRα, and PDGFRβ, respectively).1 It is selective for VEGFR, FGFR, and PDGFR over a panel of 33 kinases but does inhibit FLT3, LCK, LYN, and Src (IC50s = 16-156 nM). BIBF 1120 inhibits growth factor-dependent proliferation of human umbilical vascular endothelial cells (HUVECs), human microvascular skin endothelial cells (HSMECs), human umbilical artery smooth muscle cells (HUASMCs), and bovine retinal pericytes (BRPs; EC50s = 7-290 nM). In vivo, BIBF 1120 (100 mg/kg) reduces tumor microvessel density and the number of PDGFRβ-expressing perivascular cells in a FaDu head and neck small cell carcinoma mouse xenograft model. It also inhibits tumor growth in a Caki-1 renal cancer mouse xenograft model. Formulations containing BIBF 1120 have been used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer (NSCLC).
buy Nintedanib Ethanesulfonate Salt | Nintedanib Ethanesulfonate Salt supplier | purchase Nintedanib Ethanesulfonate Salt | Nintedanib Ethanesulfonate Salt cost | Nintedanib Ethanesulfonate Salt manufacturer | order Nintedanib Ethanesulfonate Salt | Nintedanib Ethanesulfonate Salt distributor
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft